title: [The best of interventional cardiology in 2006].
abstract: The year 2006 was a landmark in interventional cardiology. Confirmations of results of large-scale trials and meta analyses, the commercialisation of new drug-elution stents, discussions about well established methods, questions about long-term outcomes of dilated patients, have made 2006 a particularly rich year in controversy, especially during its last three months.
authors.affiliation: didier.blanchard@wanadoo.fr
authors.forename: D
authors.initials: D
authors.lastname: Blanchard
authors.forename: H
authors.initials: H
authors.lastname: Eltchaninoff
authors.forename: J
authors.initials: J
authors.lastname: Berland
authors.forename: D
authors.initials: D
authors.lastname: Carrie
authors.forename: P
authors.initials: P
authors.lastname: Dupouy
authors.forename: F
authors.initials: F
authors.lastname: Funck
authors.forename: M
authors.initials: M
authors.lastname: Gilard
authors.forename: Y
authors.initials: Y
authors.lastname: Louvard
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D002309:Cardiology / Q000639:trends*; D002318:Cardiovascular Diseases / Q000628:therapy*; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D023903:Coronary Restenosis; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015607:Stents; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine